Biocytogen Refutes Harbour BioMed’s Patent Claims, Asserts RenNano® Is Independently Developed and Legally Robust

In response to Harbour BioMed’s recent press release regarding a decision in its pending lawsuit, Biocytogen is issuing the following statement: Biocytogen operates in accordance with its core values: independent innovation, respect for intellectual property, and commitment to fair competition . The…










